{
    "Trade/Device Name(s)": [
        "OneTouch UltraLink Blood Glucose Monitoring System"
    ],
    "Submitter Information": "LifeScan, Inc.",
    "510(k) Number": "K073231",
    "Predicate Device Reference 510(k) Number(s)": [
        "K053529",
        "K040603"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "April 18, 2008",
    "Summary Letter Received Date": "April 2, 2008",
    "Submission Date": "April 1, 2008",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "OneTouch UltraLink Blood Glucose meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Radio-Frequency transmission"
    ],
    "Methodologies": [
        "Quantitative measurement",
        "In vitro diagnostic"
    ],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Reagent",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for OneTouch UltraLink Blood Glucose Monitoring System with wireless transmission capability for glucose measurement in capillary blood.",
    "Indications for Use Summary": "Intended for self-testing or professional use to quantitatively measure glucose in fresh capillary whole blood from finger, forearm or palm, and may transmit results to compatible MiniMed Paradigm and Guardian REAL Time devices via radio frequency.",
    "fda_folder": "Clinical Chemistry"
}